Nightly Business Report

Stat News reporting that the WHO posted the results of a drug trial in China that revealed Gilead’s remdesivir, an antiviral it had hoped could treat COVID-19, was ineffective. The news sent shares sinking…we talk to the reporter behind the story. And oil clawing its way back after its historic collapse earlier this week, the CEO of a tanker company joins with why that drop is a boon for his company. And new home sales falling sharply in March, Bank of America’s Michelle Meyer joins us with her near- and long-term housing forecasts.